Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tobramycin and erythromycin (Ery-tab, E.E.S.) are both antibiotics used to treat bacterial infections, but they belong to different classes. Tobramycin is an aminoglycoside antibiotic, while erythromycin is a macrolide antibiotic. Tobramycin is typically administered as an injection in a healthcare setting, whereas erythromycin is taken orally in tablet or suspension form. Tobramycin is used for serious infections like sepsis and meningitis, while erythromycin treats respiratory and skin infections. Tobramycin requires close monitoring due to potential side effects, such as hearing loss and kidney problems, whereas erythromycin commonly causes stomach-related side effects, such as nausea and diarrhea.
Tobramycin (Tobi)
Erythromycin
Tobramycin (Tobi)
Erythromycin
Summary of Tobramycin vs. Erythromycin
Summary for Aminoglycoside antibiotic
Prescription only
Tobramycin (Tobi) helps people with cystic fibrosis (CF) breathe better by controlling their Pseudomonas aeruginosa bacterial infection long term. It's inhaled through your mouth using a device (either a nebulizer or inhaler), and it can cause irritation in the mouth, throat, and lungs.
Summary for Macrolide antibiotic
Prescription only
Erythromycin is an antibiotic that's used to treat a variety of infections caused by bacteria, including certain skin and respiratory infections. The dosage depends on the specific infection you're using it for. The most common side effects are related to the stomach, like nausea, vomiting, and diarrhea. Erythromycin comes in two forms that are taken by mouth: oral tablets and an oral suspension.
Indications of Tobramycin vs. Erythromycin
Indications for
•Cystic fibrosis (CF) with Pseudomonas aeruginosa bacterial infection